CMOPF
Price:
$74
Market Cap:
$1.12B
Cosmo Pharmaceuticals N.V., a life sciences company, develops and manufactures pharmaceuticals and contracts for gastroenterology, dermatology, and health tech in Ireland and internationally. The company offers GI Genius, a computer-assisted system that uses artificial intelligence in real time to detect colorectal lesions; Winlevi, a prescription medicine used on the skin to treat acne vulgaris; Lialda/Mezavant/Mesavancol, a once-daily mesalamine tablet approved to help get active, mild to moderate ulcerative colitis into remission; Uceris/Cortiment, an oral tablet formulation that delivers budesonide directly to the lumen of the colon; Eleview, an injectable composition to allow endoscopis...[Read more]
Industry
Medical - Pharmaceuticals
IPO Date
2017-07-31
Stock Exchange
OTC
Ticker
CMOPF
According to Cosmo Pharmaceuticals N.V.’s latest financial reports and current stock price. The company's current PE Ratio is -278.89. This represents a change of 143.09% compared to the average of -114.72 of the last 4 quarters.
The mean historical PE Ratio of Cosmo Pharmaceuticals N.V. over the last ten years is -74.56. The current -278.89 PE Ratio has changed 37.30% with respect to the historical average. Over the past ten years (40 quarters), CMOPF's PE Ratio was at its highest in in the June 2007 quarter at 995.39. The PE Ratio was at its lowest in in the December 2006 quarter at -438.24.
Average
-74.56
Median
-49.69
Minimum
-491.19
Maximum
115.21
Discovering the peaks and valleys of Cosmo Pharmaceuticals N.V. PE Ratio, unveiling quarterly and yearly fluctuations to gain insights into the company’s financial performance and market dynamics, offering valuable data for investors and analysts alike.
Maximum Annual Increase = 1.26%
Maximum Annual PE Ratio = 115.21
Minimum Annual Increase = -6008.14%
Minimum Annual PE Ratio = -491.19
| Year | PE Ratio | Change |
|---|---|---|
| 2025 | -491.19 | -6008.14% |
| 2024 | 8.31 | -104.70% |
| 2023 | -176.77 | -400.31% |
| 2022 | 58.86 | 20.14% |
| 2021 | 49.00 | -134.29% |
| 2020 | -142.91 | 237.85% |
| 2019 | -42.30 | -36.63% |
| 2018 | -66.75 | 16.95% |
| 2017 | -57.08 | -149.54% |
| 2016 | 115.21 | 1.26% |
The current PE Ratio of Cosmo Pharmaceuticals N.V. (CMOPF) is less than than its 3-year, less than than its 5-year, and less than than its 10-year historical averages
3-year avg
-219.88
5-year avg
-110.36
10-year avg
-74.56
Cosmo Pharmaceuticals N.V.’s PE Ratio is less than Sawai Group Holdings Co., Ltd. (17.46), less than Kissei Pharmaceutical Co., Ltd. (11.57), less than Trulieve Cannabis Corp. (-20.10), less than Towa Pharmaceutical Co., Ltd. (36.15), less than Raffles Medical Group Ltd (24.18), less than Nippon Shinyaku Co., Ltd. (7.87), less than SSY Group Limited (15.10), less than Evotec SE (-3.15), less than China Traditional Chinese Medicine Holdings Co. Limited (-18.62), less than Genetic Technologies Limited (-0.43),
| Company | PE Ratio | Market cap |
|---|---|---|
| 17.46 | $1.33B | |
| 11.57 | $1.07B | |
| -20.10 | $1.56B | |
| 36.15 | $1.28B | |
| 24.18 | $1.38B | |
| 7.87 | $1.65B | |
| 15.10 | $1.19B | |
| -3.15 | $1.19B | |
| -18.62 | $821.34M | |
| -0.43 | $1.34B |
One of the best ways to find valuable stocks to invest in is to build a custom made screener in your Excel or Google Sheets spreadsheet. This allows you to compare thousands of companies like Cosmo Pharmaceuticals N.V. using the financials and key metrics that matter to you in a single view.
The easiest way to set this up is to use the Wisesheets add-on and set your spreadsheet like this:
Covering all these metrics from financial, data, dividend data, key metrics and more you can get all the data you want for over 50+ exchanges worldwide.
Get your free trial here.
The easiest way to analyze a company like Cosmo Pharmaceuticals N.V. or any others is to create a spreadsheet model that automatically retrieves all of the stock data you need.
Using Wisesheets you can set up a spreadsheet model like this with simple spreadsheet formulas. If you change the ticker you can get all of the data automatically updated for you.
Whether you need live data, historical price data, financials, dividend data, key metrics, analyst estimates, or anything else...Wisesheets has you covered.
What is the PE Ratio?
How can you use the PE Ratio?
What is Cosmo Pharmaceuticals N.V.'s PE Ratio?
How is the PE Ratio calculated for Cosmo Pharmaceuticals N.V. (CMOPF)?
What is the highest PE Ratio for Cosmo Pharmaceuticals N.V. (CMOPF)?
What is the 3-year average PE Ratio for Cosmo Pharmaceuticals N.V. (CMOPF)?
What is the 5-year average PE Ratio for Cosmo Pharmaceuticals N.V. (CMOPF)?
How does the current PE Ratio for Cosmo Pharmaceuticals N.V. (CMOPF) compare to its historical average?